Received Apr 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | — | — |
Extra dose (Potential); This non-serious case was reported by a other health professional via sales rep and described the occurrence of extra dose administered in a patient who received Rota (Rotarix) for prophylaxis. Previously administered products included rotarix (received the 1st dose of Rotarix vaccine on unknown date) and rotarix (received the 2nd dose of Rotarix on unknown date). On an unknown date, the patient received the 3rd dose of Rotarix. On an unknown date, an unknown time after receiving Rotarix, the patient experienced extra dose administered (Verbatim: Extra dose (Potential)). The outcome of the extra dose administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 03-APR-2025 The reporter reported that we accidentally gave a baby a third dose of Rotarix, which led to extra dose administered.